Sort
27,075 grants matching “cholesterol”
CORE--LABORATORY ANALYSIS
$350,114University Of California Los Angeles · P01 · FY2000 · HL
Project 1: Control of NASH to HCC progression by the NRF2-FBP1 tug-of-war
$350,066Michael Karin · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · CA
Cholesterol Oxidase Loop Residues and Catalysis
$350,045Nicole S. Sampson · State University New York Stony Brook · R01 · FY2006 · HL
PHASE I/II STUDIES OF EGEN-001 THERAPY FOR OVARIAN CANCER
$350,000Anwer Khursheed · Expression Genetics, Inc. · R01 · FY2007 · FD
Novel functions of plasminogen and its diverse cargo in blood
$350,000Kasey C Vickers · Vanderbilt University Medical Center · R01 · FY2025 · HL
Activator-Targeted Subunits of the ARC/Mediator
$350,000Massachusetts General Hospital · R01 · FY2005 · GM
The role of ApoE in injury-induced neurogenesis
$350,000Steven Gerard Kernie · Columbia University Health Sciences · R01 · FY2019 · NS
Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease
$350,000Charles H Vite · University Of Pennsylvania · R01 · FY2015 · NS
PHASE I/II STUDIES OF EGEN-001 THERAPY FOR OVARIAN CANCER
$350,000Anwer Khursheed · Expression Genetics, Inc. · R01 · FY2008 · FD
Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease
$350,000Charles H Vite · University Of Pennsylvania · R01 · FY2012 · NS
The role of ApoE in injury-induced neurogenesis
$350,000Steven Gerard Kernie · Columbia University Health Sciences · R01 · FY2017 · NS
Novel functions of plasminogen and its diverse cargo in blood
$350,000Kasey C Vickers · Vanderbilt University Medical Center · R01 · FY2024 · HL
Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease
$350,000Charles H Vite · University Of Pennsylvania · R01 · FY2011 · NS
PHASE I/II STUDIES OF EGEN-001 THERAPY FOR OVARIAN CANCER
$350,000Anwer Khursheed · Expression Genetics, Inc. · R01 · FY2009 · FD
ADVANCE Fellow
$349,998Dorothy I Mundy · University Of Texas Southwestern Medical Center · · FY2002 · BIO
Control of mutant p53 stability via the mevalonate pathway-DNAJA1 axis
$349,988Tomoo Iwakuma · University Of Kansas Medical Center · R01 · FY2018 · CA
Control of mutant p53 stability via the mevalonate pathway-DNAJA1 axis
$349,988Tomoo Iwakuma · University Of Kansas Medical Center · R01 · FY2020 · CA
NEIGHBORHOOD CHARACTERISTICS
$349,948Cdm Group, Inc. · N01 · FY2012 · HD
Functional Interplay of Lipid Membrane Components: Activation, Inhibition, and Raft Formation
$349,929Benjamin James Wylie · Texas Tech University · R35 · FY2021 · GM
Functional Interplay of Lipid Membrane Components: Activation, Inhibition, and Raft Formation
$349,929Benjamin James Wylie · Texas Tech University · R35 · FY2018 · GM
Functional Interplay of Lipid Membrane Components: Activation, Inhibition, and Raft Formation
$349,929Benjamin James Wylie · Texas Tech University · R35 · FY2020 · GM
Functional Interplay of Lipid Membrane Components: Activation, Inhibition, and Raft Formation
$349,929Benjamin James Wylie · Texas Tech University · R35 · FY2019 · GM
Sleep Apnea and Dysregulation of Lipid Metabolism
$349,879Vsevolod Y Polotsky · Johns Hopkins University · R01 · FY2008 · HL
The roles and functions of olfactory transduction channels in the odorant response
$349,852Johannes Reisert · Monell Chemical Senses Center · R01 · FY2022 · DC
Heart Rate and Movement Integration to Improve Physical Activity Assessment
$349,809Scott J Strath · University Of Wisconsin Milwaukee · R01 · FY2012 · HL